(BON) Bon Natural Life - Ratings and Ratios
Natural Ingredients, Fragrance Compounds, Health Supplements
BON EPS (Earnings per Share)
BON Revenue
Description: BON Bon Natural Life
Bon Natural Life Limited is a China-based company that specializes in extracting and manufacturing functional active ingredients from natural herbs, catering to various industries such as personal care, cosmetics, pharmaceuticals, and functional food. Their product portfolio includes plant-extracted fragrance compounds, natural health supplements, and bioactive food ingredients. With a global customer base, the companys products are utilized by manufacturers in multiple sectors.
Further analysis reveals that Bon Natural Life has been in operation since 2006, with its headquarters in Xian, China. The company has a strong presence in the natural ingredients market, with a diverse range of products that are used in various applications. The companys business model is focused on research and development, manufacturing, and sales, indicating a high level of vertical integration.
From a market perspective, Bon Natural Lifes stock has experienced significant volatility, with a 52-week high of $73.35 and a low of $1.30. The current price of $1.80 is above the 20-day simple moving average (SMA) of $1.54, indicating a potential short-term uptrend. However, the stock is still far below its 50-day SMA of $3.25 and 200-day SMA of $29.82, suggesting a longer-term downtrend.
Using technical and fundamental data, a forecast for Bon Natural Lifes stock can be made. The low P/E ratio of 0.49 and forward P/E of 2.35 suggest that the stock may be undervalued. Additionally, the relatively low market capitalization of $7.89M USD indicates a small-cap stock with potential for growth. However, the high volatility (ATR = 7.90%) and low return on equity (RoE = 7.12%) are concerns that need to be addressed. Based on these factors, a potential trading strategy could be to buy the stock on a sustained move above $2.00, with a target price of $3.50 in the short term, and $5.00 in the long term, contingent on the companys ability to improve its profitability and reduce volatility.
Additional Sources for BON Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BON Stock Overview
Market Cap in USD | 9m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception | 2021-06-24 |
BON Stock Ratings
Growth Rating | -85.0 |
Fundamental | -28.2 |
Dividend Rating | 0.0 |
Rel. Strength | -98.1 |
Analysts | - |
Fair Price Momentum | 1.21 USD |
Fair Price DCF | - |
BON Dividends
Currently no dividends paidBON Growth Ratios
Growth Correlation 3m | -27.2% |
Growth Correlation 12m | -93.6% |
Growth Correlation 5y | -98.6% |
CAGR 5y | -83.69% |
CAGR/Max DD 5y | -0.84 |
Sharpe Ratio 12m | -1.26 |
Alpha | -125.99 |
Beta | 2.277 |
Volatility | 118.08% |
Current Volume | 160.5k |
Average Volume 20d | 412.4k |
As of July 02, 2025, the stock is trading at USD 1.23 with a total of 160,472 shares traded.
Over the past week, the price has changed by -13.38%, over one month by -23.13%, over three months by -42.79% and over the past year by -97.94%.
Probably not. Based on ValueRay´s Fundamental Analyses, Bon Natural Life (NASDAQ:BON) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -28.23 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BON is around 1.21 USD . This means that BON is currently overvalued and has a potential downside of -1.63%.
Bon Natural Life has no consensus analysts rating.
According to our own proprietary Forecast Model, BON Bon Natural Life will be worth about 1.4 in July 2026. The stock is currently trading at 1.23. This means that the stock has a potential upside of +16.26%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 77.5 | 6200.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 1.4 | 16.3% |